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Seven commercial rotavirus antigen assays were compared with in-house PCRmethods for detecting rotavirus in stool speci-
mens. The assay sensitivities were 80% to 100%, while the specificities were 54.3% for one commercial immunochromatographic
(ICT) method and 99.4% to 100% for other assays. Thus, except for one commercial ICT, all the assays were generally reliable for
rotavirus detection.
An estimated 453,000 children die annually of severe rotavirus-related gastroenteritis, with most deaths occurring in devel-
oping countries (1). In the prevaccine era, rotavirus caused 10,000
hospitalizations, 22,000 emergency department visits, and
115,000 general practice consultations in Australian children aged
5 years (2). Our recent findings (3) raised concerns regarding
the specificity of the Vikia Rota-Adeno assay (bioMérieux,
France) for detecting rotavirus in stool samples and followed an
unexplained increase in positive results in a highly vaccinated
population in which surveillance had previously shown rotavirus
vaccine to have been highly effective in significantly reducing ro-
tavirus notifications and rotavirus-related hospitalizations (4, 5).
In that study (3), we found that, of 81 available stool specimens
submitted for diagnostic testing (collected between July 2011 and
August 2012) and reported as positive using the Vikia kit, only
28% to 37% could be confirmed as positive using additional real-
time reverse transcriptase (RT)-PCR and enzyme-linked immu-
nosorbent assay (ELISA)-based testing. The results were highly
suggestive of an unacceptably low specificity in the Vikia rotavirus
immunochromatographic (ICT) assay. In this follow-up study,
we sought to examine whether false positivity in the Vikia kit is an
ongoing problem and to assess the performance of a wider range
of ICT and ELISA rotavirus detection methods.
Convenience sampling of stool specimens submitted from pa-
tients with acute gastroenteritis to the publicly funded Central
Microbiology Laboratory of Pathology in Queensland, Brisbane,
Australia, for rotavirus testing occurred between July 2012 and
June 2013. Samples were tested initially for rotavirus using the
Vikia ICTmethod. Only samples with sufficient volumes for sub-
sequent testing were included in the study. These were stored at
20°C until they underwent further testing by the additional as-
says. Overall, 182 stool samples from patients up to 94 years of age
(median, 11 years; mean, 28 years) were included; the samples
were from 101 males and 81 females. There were Vikia rotavirus-
positive (n 92) andVikia rotavirus-negative (n 90) specimens
in this sample.We tested these specimenswith six additional com-
mercial rotavirus tests (three ICT kits and three ELISAs) and three
in-house real time RT-PCR assays (Tables 1 and 2). All the ICT
assays and ELISAs were performed according to their manufac-
turer’s instructions. Performance characteristics according to the
kit inserts are listed in Table S1 in the supplemental material. The
RT-PCR methods comprised two TaqMan-based real-time RT-
PCR assays (NVP3-PCR and JVK-PCR) and a conventional PCR
(VP6 RT-PCR) and were performed as described previously (3).
The oligonucleotide primers and probes used in the real-time RT-
PCR assays are provided in Table S2 in the supplemental material.
In order to confirm the initial Vikia assay results, we retested all
specimens with the Vikia assay according to the manufacturer’s in-
structions. The test performance characteristics from this study for
each assay are reported as their sensitivity, specificity, and true-posi-
tive and true-negative proportions. The 95%confidence intervals for
each of these values were calculated using Stata version 12 (Stata
Corp, College Station, TX). The Children’s Health Queensland Hu-
man Research Ethics Committee approved the study.
The results for the 182 specimens with each kit and the associ-
ated performance characteristics are summarized in Tables 1 and
2, respectively. Overall, there was close agreement between all
methods with the exception of the Vikia assay. Specifically, 67 of
the 90 (74%) samples that were positive in the Vikia test were
negative in every other assay evaluated upon retesting (Table 1).
When the Vikia results were excluded, only 12 (6.6%) of the 182
samples provided discrepant results among the remaining ICT,
ELISA, andPCRmethods. The performance characteristics (Table
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2) were determined on the basis of a reference standard whereby
samples that provided positive results in three or more methods
were considered true positives; all other samples were considered
true negatives. On the basis of this standard, the sensitivities of the
kits ranged from 80% to 100%. Specificity was lowest for the Vikia
kit at 54.3%, whereas observed specificities for the remaining
methods were 99.4% to 100%. None of the assays achieved the
sensitivities described in their kit inserts. However, this is most
likely due to the use of PCR assays in this study, whereas most
antigen-based assays would have been validated using other anti-
gen-based methods. In fact, including PCR test results within the
reference standard may be viewed as having negatively biased the
sensitivity values for other the assays, as PCR can detect low-level
virus shedding from infection weeks earlier and unrelated to the
current illness (6). This is further reflected in those samples pro-
viding negative results by one ormore antigen-basedmethods but
being positive by real-time PCR, with their cycle threshold (CT)
values exceeding 33 cycles (Table 1). These particular CT values
were among the highest observed and indicated a low viral load. An-
other limitationofour studywas that therewereonly20 true-positive
samples, and this may have influenced the certainty around sensitiv-
ity calculations, as shown by the broad 95% confidence intervals as-
sociatedwith these data. In contrast, except for theVikiamethod, the
specificities for all the other commercial methods were comparable
with those reported by the manufacturers.
These data show that the specificity problems observed previ-
ously with the Vikia assay (3) remain and that the same problems
are not evident with the other ICT or ELISA methods we studied.
Based on our results, PCR provided the best overall sensitivity and
specificity. While the antigen tests were not as sensitive as PCR,
they, excluding the Vikia, were highly specific. We therefore agree
with a recent international study of childhood diarrhea evaluating
molecular-based detection techniques, which found that antigen
testing remained suitable for rapidly diagnosing rotavirus infec-
tion in clinical samples (7).
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TABLE 2 Performance characteristics of each rotavirus assay applied to 182 samples from Queensland between July 2012 and June 2013a
Assay type TP (n) TN (n) FP (n) FN (n)
TP/RefP (sensitivity
[%] [95% CI])b
TN/RefN (specificity
[%] [95% CI])b
TP/TP FP (% TP
[95% CI])b
TN/TN FN (% TN
[95% CI])b
Vikia initial 18 88 74 2 90.0 (68.3–98.8) 54.3 (46.3–62.2) 19.6 (12.0–29.1) 97.8 (92.2–99.7)
Vikia repeat 18 88 74 2 90.0 (68.3–98.8) 54.3 (46.3–62.2) 19.6 (12.0–29.1) 97.8 (92.2–99.7)
SD Bioline 17 161 1 3 85.0 (62.1–96.8) 99.4 (96.6) 94.4 (72.7–99.9) 98.2 (94.7–99.6)
CerTest 17 162 0 3 85.0 (62.1–96.8) 100.0 (97.7) 100.0 (80.5) 98.2 (94.8–99.6)
QuickStripe 17 162 0 3 85.0 (62.1–96.8) 100.0 (97.7) 100.0 (80.5) 98.2 (94.8–99.6)
Rotaclone 17 161 1 3 85.0 (62.1–96.8) 99.4 (96.6) 94.4 (72.7–99.9) 98.2 (94.7–99.6)
Ridascreen 16 162 0 4 80.0 (56.3–94.3) 100.0 (97.7) 100.0 (79.4) 97.6 (93.9–99.3)
ProSpecT 18 162 0 2 90.0 (68.3–98.8) 100.0 (97.7) 100.0 (81.5) 98.8 (95.7–99.9)
ROTA NVP3 20 161 1 0 100.0 (83.2) 99.4 (96.6) 95.2 (76.2–99.9) 100.0 (97.7)
ROTA JVK 19 161 1 1 95.0 (75.1–99.9) 99.4 (96.6) 95.0 (75.1–99.9) 99.4 (96.6)
ROTA VP6 20 158 4 0 100.0 (83.2) 99.4 (93.8–99.3) 83.3 (62.6–95.3) 100.0 (97.7)
a RefP, positive by the reference standard criteria; RefN, negative by the reference standard criteria; CI, confidence interval (considered a true positive if rotavirus was detected in
three or more tests [RefP], otherwise considered a true negative [RefN]); TP, true positive; TN, true negative; FP, false positive; FN, false positive.
b Where the percentage point estimate is 100%, the lower 97.5% confidence limit is provided.
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